| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ATCC 29213 + anaerobic) |
- |
- |
8 － ? |
Gentamicin (Gentamycin, Garamycin)  |
248 |
| Staphylococcus aureus (ATCC 29213 + culture: LB-broth) |
- |
- |
0.08 － ? |
Serraticin A |
868 |
| Staphylococcus aureus (ATCC 29213 + culture: M9-Glucose) |
- |
- |
0.64 － ? |
Serraticin A |
868 |
| Staphylococcus aureus (ATCC 29213 + initial) |
- |
- |
0.06 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (ATCC 29213 + initial) |
- |
- |
0.06 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + linezolid-resistant) |
- |
- |
0.12 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
192 |
| Staphylococcus aureus (ATCC 29213 + linezolid-resistant) |
- |
- |
1 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
192 |
| Staphylococcus aureus (ATCC 29213 + linezolid-resistant) |
- |
- |
1 － ? |
TR-700 |
192 |
| Staphylococcus aureus (ATCC 29213 + linezolid-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
192 |
| Staphylococcus aureus (ATCC 29213 + linezolid-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
192 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible + CAMHB + pH 5.8) |
- |
- |
0.125 － ? |
Finafloxacin |
1045 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible + CAMHB + pH 5.8) |
- |
- |
2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible + CAMHB + pH 7.2) |
- |
- |
0.25 － ? |
Finafloxacin |
1045 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible + CAMHB + pH 7.2) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
0.03 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
0.12 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Arbekacin |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Cefazolin (Ancef, Kefzol, Zolicef) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Cefpirome |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
624 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Flomoxef |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Gentamicin (Gentamycin, Garamycin) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Imipenem |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Levofloxacin (Levaquin, Quixin) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
≤0.5 － ? |
Teicoplanin (Targocid) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
Cefmetazole |
1398 |